Status:
TERMINATED
Outcomes of Neonates Born to Mothers With SARS-CoV-2 Infection in Shanghai
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
SARS-CoV2 Infection
Neonatal Infection
Eligibility:
All Genders
Up to 28 years
Brief Summary
Since March 2022, there are an outbreak of SARS-CoV-2 infection (Omicron) in Shanghai. This cohort study aims to analysis the clinical outcomes of neonates born to mothers with SARS-CoV-2 infection.
Eligibility Criteria
Inclusion
- Neonates born to mothers with SARS-CoV-2 infections.
Exclusion
- Parents who rejected to participate in this study.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT05379452
Start Date
March 1 2022
End Date
January 1 2023
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children Hospital of Fudan University
Shanghai, China, 201102